IQVIA controls one of the world's largest databases of healthcare information that's closely integrated the clinical research ...

CINCINNATI, June 21, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company spanning multiple sectors, today ...

Morgan Stanley raised Charles River's price target to $220 and cut IQVIA's to $200, citing biopharma funding trends and AI ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Broyhill Asset Management, an investment advisor, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 witnessed extreme market concentration and a ...

Flagship Pioneering’s portfolio includes a suite of platform-focused biotechs that will benefit from IQVIA’s expertise. (pierivb/Getty Images) Flagship Pioneering is boosting the clinical research ...

Morgan Stanley upgraded contract research organization (CRO) provider Charles River Laboratories while downgrading IQVIA, arguing that improving biotech funding and portfolio changes create a more ...

One of the critical challenges in clinical trials is patient recruitment and retention. IQVIA Biotech’s comprehensive approach to patient recruitment leverages a blend of traditional and innovative ...

Good morning, everybody. Luke Sergott. I cover life science tools and diagnostics for Barclays. With me, I have Mike Fedock, CFO of IQVIA. Yes, yes, absolutely. No, great question and obviously ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences ...

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.